Literature DB >> 18046647

Integrating epidemiological data into a mechanistic model of type 2 diabetes: validating the prevalence of virtual patients.

David J Klinke1.   

Abstract

Mathematical models are playing an increasing role in understanding the complexity of multifactorial diseases like type 2 diabetes. The objective of this study was to validate a population of virtual patients against a real population of patients with type 2 diabetes. A population of virtual patients was created that incorporates different underlying pathogenic lesions consistent with a type 2 diabetic phenotype. These virtual patients were created within the Metabolism PhysioLab platform, a non-linear coupled differential algebraic model that incorporates the salient causal mechanisms underlying glucose homeostasis and substrate metabolism. The weights of each individual virtual patient were determined to reproduce the diversity in a real type 2 diabetic population obtained from the NHANES III study. As a validation test, this virtual population reproduced a series of clinical studies that identify less invasive biomarkers for insulin sensitivity. This approach demonstrates how computational bridges can be constructed between statistical approaches common in epidemiology and deterministic approaches common in biomedical engineering.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18046647     DOI: 10.1007/s10439-007-9410-y

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  17 in total

1.  Evaluating optimal therapy robustness by virtual expansion of a sample population, with a case study in cancer immunotherapy.

Authors:  Syndi Barish; Michael F Ochs; Eduardo D Sontag; Jana L Gevertz
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

2.  QSP Toolbox: Computational Implementation of Integrated Workflow Components for Deploying Multi-Scale Mechanistic Models.

Authors:  Yougan Cheng; Craig J Thalhauser; Shepard Smithline; Jyotsna Pagidala; Marko Miladinov; Heather E Vezina; Manish Gupta; Tarek A Leil; Brian J Schmidt
Journal:  AAPS J       Date:  2017-05-24       Impact factor: 4.009

Review 3.  Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus.

Authors:  Cornelia B Landersdorfer; William J Jusko
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

4.  Validating a dimensionless number for glucose homeostasis in humans.

Authors:  David J Klinke
Journal:  Ann Biomed Eng       Date:  2009-06-10       Impact factor: 3.934

5.  A conceptual review on systems biology in health and diseases: from biological networks to modern therapeutics.

Authors:  Pramod Rajaram Somvanshi; K V Venkatesh
Journal:  Syst Synth Biol       Date:  2013-09-18

Review 6.  A multiscale systems perspective on cancer, immunotherapy, and Interleukin-12.

Authors:  David J Klinke
Journal:  Mol Cancer       Date:  2010-09-15       Impact factor: 27.401

Review 7.  Enhancing the discovery and development of immunotherapies for cancer using quantitative and systems pharmacology: Interleukin-12 as a case study.

Authors:  David J Klinke
Journal:  J Immunother Cancer       Date:  2015-06-16       Impact factor: 13.751

8.  Alternate virtual populations elucidate the type I interferon signature predictive of the response to rituximab in rheumatoid arthritis.

Authors:  Brian J Schmidt; Fergal P Casey; Thomas Paterson; Jason R Chan
Journal:  BMC Bioinformatics       Date:  2013-07-10       Impact factor: 3.169

Review 9.  Bridging Systems Medicine and Patient Needs.

Authors:  J-P Boissel; C Auffray; D Noble; L Hood; F-H Boissel
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-03-27

10.  Systems biology for simulating patient physiology during the postgenomic era of medicine.

Authors:  B J Schmidt
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.